How are substance-use treatment outcomes typically evaluated?

• A. Retention, abstinence or reduced use, improvements in functioning and quality of life, reduced healthcare utilization, and relapse rates.
• B. Only patient preference matters.
• C. Treatment outcomes are not tracked.
• D. Success equals complete cure in all cases.

Answer: (A)

Outcomes in substance-use treatment are evaluated using multiple dimensions that reflect engagement, behavior change, functioning, and system impact. Retention in treatment shows that a person remains engaged, which is important because ongoing participation is often linked to better long-term results. Abstinence or reduced use measures directly track changes in the core behavior the treatment aims to affect. Improvements in functioning and quality of life capture how changes translate into daily life, relationships, work, and overall well-being. Reduced healthcare utilization indicates fewer health problems and lower system burden, while relapse rates provide information about the durability of the change over time. These mixed indicators together give a fuller picture than any single measure. Other options fall short because patient preference alone doesn’t provide objective, comprehensive data; outcomes are tracked to guide care and public health understanding; and declaring complete cure in all cases ignores the chronic and sometimes relapsing nature of substance-use disorders.